IL10 and myeloid sarcoma: Therefore, the results can only be regarded as hypothesis-generating, and studies of larger cohorts or more homozygous patients are needed to certify associations between the polymorphisms and Th1- and IL-10 responses to MBP or other MS-associated self-antigens.